C
Collegium Pharmaceutical D
D
COLL
29.090
USD
-0.04
(-0.14%)
مغلق
حجم التداول
3,685
الربح لكل سهم
6
العائد الربحي
-
P/E
12
حجم السوق
938,159,365
المقالات
العنوان: Collegium Pharmaceutical
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.